Friday, April 26, 2024
ADVT 
Health

Surgery backlog could take 84 weeks to clear: study

Darpan News Desk The Canadian Press, 01 Sep, 2020 07:32 PM
  • Surgery backlog could take 84 weeks to clear: study

A new study suggests it could take more than a year and a half to clear the backlog of surgeries in Ontario hospitals caused by the COVID-19 pandemic.

Modelling research published today in the Canadian Medical Association Journal says the estimated time to clear surgeries postponed due to the pandemic is 84 weeks, with a target of 717 surgeries per week.

The provincial government instructed Ontario hospitals to cancel elective surgeries and other activities deemed not urgent in mid-March to prepare for a possible surge of COVID-19 patients.

That directive was lifted in late May and hospitals gradually resumed performing those surgeries.

The study says that between March 15 and June 13, Ontario hospitals accrued a backlog of 148,364 procedures.

Its authors say the data will play an important role in health planning moving forward, and the modelling framework can be adapted to other jurisdictions.

"The magnitude of the surgical backlog from COVID-19 raises important implications for planning for the recovery phase and for possible second waves of the pandemic in Ontario," study co-author Dr. Jonathan Irish, a surgeon at Princess Margaret Cancer Centre in Toronto, said in a statement.

The researchers say health systems "cannot go back to business as usual" if they want to manage the impact on patients, and must find innovative solutions to prepare for future waves of the novel coronavirus.

MORE Health ARTICLES

Serious coronavirus-linked condition hit 285 US children

Serious coronavirus-linked condition hit 285 US children
At least 285 U.S. children have developed a serious inflammatory condition linked to the coronavirus and while most recovered, the potential for long-term or permanent damage is unknown, two new studies suggest.

Serious coronavirus-linked condition hit 285 US children

Tattoo artist sees bump in desire to erase hateful skin art

Tattoo artist sees bump in desire to erase hateful skin art
A Vermont tattoo artist who has long offered free removal or covering of hateful skin art like swastikas, SS lightning bolts or the words “white power” says he’s seen an uptick in business recently following George Floyd's death.

Tattoo artist sees bump in desire to erase hateful skin art

Travellers to NY, New Jersey, Connecticut are told to isolate

Travellers to NY, New Jersey, Connecticut are told to isolate
New York, Connecticut and New Jersey will require visitors from states with high infection rates to quarantine for 14 days, New York Gov. Andrew Cuomo said Wednesday.

Travellers to NY, New Jersey, Connecticut are told to isolate

Open wide: US dentists quickly rebuild after virus shutdown

Open wide: US dentists quickly rebuild after virus shutdown
U.S. dental offices are quickly bouncing back, but it won't be business as usual. Expect social distancing, layers of protective gear and a new approach to some procedures to guard against coronavirus.

Open wide: US dentists quickly rebuild after virus shutdown

Virus cases surging among the young, endangering the elderly

Virus cases surging among the young, endangering the elderly
Coronavirus cases are climbing rapidly among young adults in a number of states where bars, stores and restaurants have reopened — a disturbing generational shift that not only puts them in greater peril than many realize but poses an even bigger danger to older people who cross their paths.

Virus cases surging among the young, endangering the elderly

Vancouver biotech company discovering antibodies for COVID-19 treatment

Vancouver biotech company discovering antibodies for COVID-19 treatment
There may be another valuable shield in the fight against COVID-19, and the head of a Vancouver biotech firm says it could buy time as researchers race to develop a vaccine. Carl Hansen, CEO of AbCellera Biologics Inc., said a drug built with antibodies could be used to protect vulnerable populations until a vaccine is more widely available.    

Vancouver biotech company discovering antibodies for COVID-19 treatment